"10.1371_journal.pone.0015921","plos one","2011-01-14T00:00:00Z","Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel","Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany; Hannover Medical School, Institute of Pathology, Hannover, Germany; Universitätsfrauenklinik Heidelberg, Heidelberg, Germany; LFB Biotechnologies - Research Department, Lille, France","Conceived and designed the experiments: HT LT RvW TS ITE CKB BF NF CdR MH SD. Performed the experiments: HT LT JL RvW ITE BF NF. Analyzed the data: HT LT JL RvW TS ITE CKB BF NF CdR MH SD. Contributed reagents/materials/analysis tools: GB. Wrote the paper: LT HT CKB MH SD.","Isabel Tourais Esteves, Christian K. Behrens, Bénédict Fournes, Nathalie Fournier and Christophe de Romeuf are employees of LFB Biotechnologies, Holger Thie is employed by Miltenyi Biotec GmbH and Lars Toleikis is employed by Merck KGaA. The authors Holger Thie, Lars Toleikis, Thomas Schirrmann, Christian K. Behrens (LFB), Christophe de Romeuf (LFB), Michael Hust and Stefan Dübel are inventors on a patent application regarding anti-MUC1 antibodies (PCT/EP2009/005218). This study was partly financed by LFB. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","01","Holger Thie","HT",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
